Adolescent HIV prevention and care network in Chicago
Official title: The Hektoen Institute of Medical Research Site Consortium - Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional)
Funded at Westat, INC. · NIH-11367860 · Data updated 2026-11-12
This program builds and runs HIV prevention and treatment programs for teens and young adults (ages 13–24), with extra focus on underserved communities in the Chicago area.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Westat, INC. NIH-funded |
| Lab location | 1 site (Bethesda, UNITED STATES) |
| Project start | September 22, 2022 |
| Project end | October 9, 2029 |
| Funding year | 2025 |
| Award (this year) | $357,900 |
| NIH project number | 5UM2HD111076-04 |
| Project ID | NIH-11367860 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal participants are adolescents and young adults ages 13–24 who are at risk for or living with HIV, especially those from low-income, racial/ethnic minority, sexual or gender minority, or substance-using communities in the Chicago area.
✕Less likely to help
People outside the 13–24 age range or those who do not live in or cannot access services in the Chicagoland area are unlikely to be eligible or receive direct benefit from this program.
What this research studies
You would be joining a network that helps design and carry out prevention and treatment efforts for HIV among adolescents and young adults. The team works with clinical and community partners to recruit and keep young people in services, protect participant safety, and use new outreach methods to reach high-risk groups. Work covers prevention, testing, and care support for ages 13–24 and can include clinical trials or other interventional activities. The local consortium centers its efforts on underserved neighborhoods in the Chicagoland area to reach people who face barriers to care.
Why it matters
Potential benefit: If successful, this work could lower new HIV infections and improve access to prevention and treatment for teens and young adults in high-risk communities.
How similar studies have gone: The Adolescent Medicine Trials Network (ATN) has operated since 2001 and prior ATN efforts have produced successful prevention and care approaches for youth, so this continues established work.
Where this research is happening
-
Westat, INC.
Bethesda, United States Active
Researchers
- Principal investigator: Simpson, Karen — Westat, INC.
- Study coordinator: Simpson, Karen
Related research
Other NIH-funded projects on the same topics.
-
An integrated mobile health program to reduce SAVA and mental health problems among female sex workers in Kenya
A new mobile health program aims to help female sex workers in Kenya avoid substance abuse, violence, HIV, and depression by delivering group therapy, online resources, and a peer discussion space.
-
FIOCRUZ HIV/AIDS Clinical Trials Unit: advancing HIV prevention and treatment in Brazil
A Brazilian clinical trials unit led by Dr. Beatriz Grinsztejn is testing and speeding up new HIV prevention and treatment strategies to help people living with HIV/AIDS and those at risk.
-
Breeding colony expansion to support HIV/AIDS research with rhesus macaques
A funding opportunity to expand a specialized Rhesus macaque breeding population to support HIV/AIDS research at Tulane’s primate facility.
-
HIV Resilience Observatory in a rhesus macaque colony expansion
A program to build a rhesus macaque breeding colony and use AI-powered monitoring to study why some HIV/AIDS outcomes differ among individuals with similar backgrounds.
-
Indoor-Outdoor Housing Expansion to Support HIV/AIDS-Related Research
A HIV-focused project at a primate research center will use new indoor/outdoor housing and AI-assisted monitoring to study why people with similar backgrounds can have very different HIV outcomes.
-
Hearing changes in people with HIV and in people without HIV in Tanzania
This project follows people living with HIV and similar individuals in Tanzania to see how hearing and brain function relate over time and whether hearing tests can help predict cognitive changes.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.